Literature DB >> 16749859

Efflux mechanism of taurocholate across the rat intestinal basolateral membrane.

Shingo Sakamoto1, Hiroshi Suzuki, Hiroyuki Kusuhara, Yuichi Sugiyama.   

Abstract

We investigated the contribution of multidrug resistance associated protein 3 (Mrp3/ABCC3) to the transport of bile acids across the rat intestinal basolateral membrane using the everted sacs. The permeability-surface area (PS) products of taurocholate in the everted sacs of rat jejunum, ileum, and colon were determined in the absence or presence of inhibitors for Mrp3. The results were analyzed to determine the PS product for the uptake across the apical membrane (PS1) and that for the efflux across the basolateral membrane (PS3). The mucosal-to-serosal transport of taurocholate in the ileum was the highest. The concentration-dependent inhibitory effects by all inhibitors in the ileum were observed on both PS1 and PS3 for taurocholate. However, even in the presence of 1 mM of each inhibitor, the decrease of PS3 was low. Additionally, PS3 in the colon, where Mrp3 is expressed at a high level, was not inhibited by MK571 and taurolithocholate-3-sulfate. Unlike PS1, PS3 did not exhibit saturation at the concentration examined. These results suggest that Mrp3 makes only a minor contribution to the efflux of bile acids across the basolateral membrane. Ostalpha-Ostbeta heteromeric transporter is certainly one of the good candidates for such a transporter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16749859     DOI: 10.1021/mp050101+

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse.

Authors:  Yoshiaki Kitamura; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2010-02-11       Impact factor: 4.200

2.  Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer.

Authors:  Masato Kobayashi; Takafumi Tsujiuchi; Yuya Okui; Asuka Mizutani; Kodai Nishi; Takeo Nakanishi; Ryuichi Nishii; Kazuki Fukuchi; Ikumi Tamai; Keiichi Kawai
Journal:  Pharm Res       Date:  2018-11-29       Impact factor: 4.200

Review 3.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

Review 4.  Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery.

Authors:  Robin Durník; Lenka Šindlerová; Pavel Babica; Ondřej Jurček
Journal:  Molecules       Date:  2022-05-05       Impact factor: 4.927

5.  Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.

Authors:  Christopher Yip; Naomi C Okada; Amber Howerton; Amei Amei; Ernesto Abel-Santos
Journal:  Biochem Pharmacol       Date:  2020-11-03       Impact factor: 5.858

6.  Imaging of hepatic drug transporters with [131I]6-β-iodomethyl-19-norcholesterol.

Authors:  Masato Kobayashi; Kodai Nishi; Asuka Mizutani; Tsuzumi Hokama; Miki Matsue; Tetsuya Tsujikawa; Takeo Nakanishi; Ryuichi Nishii; Ikumi Tamai; Keiichi Kawai
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.